Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments

被引：22

作者：

Bautista-Aguilera, Oscar M. ^{[1
]}

Ismaili, Lhassane ^{[2
]}

Iriepa, Isabel ^{[1
,3
]}

Diez-Iriepa, Daniel ^{[1
]}

Chabchoub, Fakher ^{[4
]}

Marco-Contelles, Jose ^{[5
]}

Perez, Marta ^{[6
]}

机构：

[1] Univ Alcala, Dept Quim Organ & Quim Inorgan, Ctra Madrid Barcelona,Km 33,6, Madrid 28871, Spain

[2] Univ Bourgogne Franche Comte, Lab Chim Organ & Therapeut, Neurosci Integrat & Clin EA 481, UFR Sante, 19 Rue Ambroise Pare, F-25000 Besancon, France

[3] Alcala Univ, Inst Chem Res Andres M del Rio, Madrid 28805, Spain

[4] Univ Sfax, Lab Chim Appl Heterocycles Corps Gras & Polymeres, Fac Sci Sfax, BP 802, Sfax 3000, Tunisia

[5] CSIC, Lab Med Chem IQOG, Juan de la Cierva 3, Madrid 28006, Spain

[6] Univ Basque Country, Publ Hlth Dept, Fac Med & Nursing, Leioa, Spain

来源：

CHEMICAL RECORD | 2021年 / 21卷 / 01期

关键词：

Alzheimer' s disease; Cholinesterase inhibition; Friedlä nder reaction; Hepatotoxicity; Tacrine derivatives; BIOLOGICAL ASSESSMENT; DIRECTED LIGANDS; SENILE DEMENTIA; ACETYLCHOLINESTERASE; INHIBITORS; DRUGS; FLUORESCEIN; MELATONIN; HYBRIDS; DESIGN;

D O I：

10.1002/tcr.202000107

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Herein we have reviewed our recent developments for the identification of new tacrine analogues for Alzheimer's disease (AD) therapy. Tacrine, the first cholinesterase inhibitor approved for AD treatment, did not stop the progression of AD, producing only some cognitive improvements, but exhibited secondary effects mainly due to its hepatotoxicity. Thus, the drug was withdrawn from the clinics administration. Since then, many publications have described non-hepatotoxic tacrines, and in addition, important efforts have been made to design multitarget tacrines by combining their cholinesterase inhibition profile with the modulation of other biological targets involved in AD.

引用

页码：162 / 174

页数：13

共 49 条

[41] Rational approach to discover multipotent anti-Alzheimer drugs
Rosini, M
Andrisano, V
Bartolini, M
Bolognesi, ML
Hrelia, P
Minarini, A
Tarozzi, A
Melchiorre, C
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) : 360 - 363
[42] Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles
Samadi, Abdelouahid
Valderas, Carolina
de los Rios, Cristobal
Bastida, Agatha
Chioua, Mourad
Gonzalez-Lafuente, Laura
Colmena, Ines
Gandia, Luis
Romero, Alejandro
del Barrio, Laura
Martin-de-Saavedra, Maria D.
Lopez, Manuela G.
Villarroya, Mercedes
Marco-Contelles, Jose
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (01) : 122 - 133
[43] Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles
Samadi, Abdelouahid
Marco-Contelles, Jose
Soriano, Elena
Alvarez-Perez, Monica
Chioua, Mourad
Romero, Alejandro
Gonzalez-Lafuente, Laura
Gandia, Luis
Roda, Jose M.
Lopez, Manuela G.
Villarroya, Mercedes
Garcia, Antonio G.
de los Rios, Cristobal
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (16) : 5861 - 5872
[44] Dementia in the acute hospital: prospective cohort study of prevalence and mortality
Sampson, Elizabeth L.
Blanchard, Martin R.
Jones, Louise
Tookman, Adrian
King, Michael
[J]. BRITISH JOURNAL OF PSYCHIATRY, 2009, 195 (01) : 61 - 66
[45] Two new indoloquinoline alkaloids from Cryptolepis sanguinolenta: Cryptosanguinolentine and cryptotackieine
Sharaf, MHM
Schiff, PL
Tackie, AN
Phoebe, CH
Martin, GE
[J]. JOURNAL OF HETEROCYCLIC CHEMISTRY, 1996, 33 (02) : 239 - 243
[46] ORAL TETRAHYDROAMINOACRIDINE IN LONG-TERM TREATMENT OF SENILE DEMENTIA, ALZHEIMER TYPE
SUMMERS, WK
MAJOVSKI, LV
MARSH, GM
TACHIKI, K
KLING, A
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (20) : 1241 - 1245
[47] Valence bond theory for chemical dynamics
Truhlar, Donald G.
[J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2007, 28 (01) : 73 - 86
[48] 5-Methyl-N-(8-(5,6,7,8-tetrahydroacridin-9-ylamino) octyl)-5H-indolo[2,3-b] quinolin-11-amine: a highly potent human cholinesterase inhibitor
Wang, Li
Moraleda, Ignacio
Iriepa, Isabel
Romero, Alejandro
Lopez-Munoz, Francisco
Chioua, Mourad
Inokuchi, Tsutomu
Bartolini, Manuela
Marco-Contelles, Jose
[J]. MEDCHEMCOMM, 2017, 8 (06) : 1307 - 1317
[49] WHITE P, 1977, LANCET, V1, P668

← 1 2 3 4 5 →